{
  "abstract": "Liver X receptors (LXRs), comprising LXRα and LXRβ, are oxysterol-responsive nuclear receptors that regulate cholesterol homeostasis and inflammatory signaling. In the central nervous system (CNS), LXR activity influences amyloid-β metabolism, glial responses, synaptic integrity, myelination, and blood–brain barrier function. This narrative review synthesizes shared and disease-specific mechanisms across neurodegenerative and demyelinating disorders, distinguishing established experimental effects from proposed pathways. We compare representative LXR modulators by receptor and transcriptional selectivity, CNS exposure, efficacy, and safety. Particular attention is given to hepatic lipogenesis caused by systemic LXRα activation and to LXRβ-selective or function-selective ligands, brain-targeted delivery, combination strategies, and biomarker-guided patient stratification. Although preclinical findings support therapeutic potential, clinical efficacy remains unproven. Priorities include cell-type-specific causal validation, quantitative CNS target engagement, and long-term safety assessment.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Pharmaceutical Engineering, School of Food and Pharmaceutical Engineering, Zhaoqing University, Zhaoqing 526061, China",
    "Department of Pharmacology of Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China",
    "Key Laboratory for Research and Utilization of Southern Medicine, Zhaoqing University, Zhaoqing 526061, China",
    "Risk Assessment Laboratory for Agricultural Product Quality and Safety, Ministry of Agriculture and Rural Development, Zhaoqing University, Zhaoqing 526061, China"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 7,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Hancheng Li"
    },
    {
      "affs": [
        0
      ],
      "name": "Jinwei Gan"
    },
    {
      "affs": [
        0
      ],
      "name": "Peng Zeng"
    },
    {
      "affs": [
        1
      ],
      "name": "Chaohua Luo"
    },
    {
      "affs": [
        2
      ],
      "name": "Wenhua Liu"
    },
    {
      "affs": [
        0,
        3
      ],
      "name": "Hongwu Wang"
    },
    {
      "affs": [
        1
      ],
      "name": "Zhixian Mo"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6dg7tz2b9y7hp.bib",
  "cited_by": 0,
  "doi": "10.3390/biom16111654",
  "fulltext_url": null,
  "id": "6dg7tz2b9y7hp",
  "issns": [
    "2218-273X"
  ],
  "landing_url": "https://www.mdpi.com/2218-273X/16/11/1654",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-12",
  "publisher": "MDPI AG",
  "ris": "https://research.draconitic.com/paper/6dg7tz2b9y7hp.ris",
  "sources": [
    {
      "first_seen": "2026-11-13T00:21:14Z",
      "native_id": "10.3390/biom16111654",
      "source": "crossref",
      "url": "https://www.mdpi.com/2218-273X/16/11/1654"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "issn:2218-273X",
      "subfield": "general"
    }
  ],
  "title": "Liver X Receptors in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential",
  "title_text": "Liver X Receptors in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential",
  "type": "peer-reviewed",
  "updated_at": "2026-11-14T00:20:51Z",
  "url": "https://research.draconitic.com/paper/6dg7tz2b9y7hp",
  "venue": "Biomolecules",
  "versions": []
}